CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 26,566	$ 42,694
Restricted cash	22,198	3,075
Patient accounts receivable	305,413	274,961
Prepaid expenses	15,199	10,356
Other current assets	25,493	25,598
Total current assets	394,869	356,684
Property and equipment, net of accumulated depreciation of $100,265 and $96,937	17,847	18,435
Operating lease right of use assets	107,723	101,257
Goodwill	1,289,672	1,196,090
Intangible assets, net of accumulated amortization of $9,109 and $19,900	106,189	111,190
Deferred income tax assets	0	289
Other assets	84,686	73,023
Total assets	2,000,986	1,856,968
Current liabilities:
Accounts payable	43,509	38,217
Payroll and employee benefits	161,068	141,001
Accrued expenses	176,239	150,836
Current portion of long-term obligations	12,521	12,995
Current portion of operating lease liabilities	34,035	31,233
Total current liabilities	427,372	374,282
Long-term obligations, less current portion	442,413	432,075
Operating lease liabilities, less current portion	72,619	69,309
Deferred income tax liabilities	6,179	0
Other long-term obligations	13,408	4,979
Total liabilities	961,991	880,645
Commitments and Contingencies—Note 6
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 37,780,242 and 37,674,868 shares issued; and 32,432,527 and 32,509,969 shares outstanding	38	38
Additional paid-in capital	743,276	728,118
Treasury stock, at cost 5,347,715 and 5,164,899 shares of common stock	(457,981)	(435,868)
Retained earnings	700,313	639,063
Total Amedisys, Inc. stockholders’ equity	985,646	931,351
Noncontrolling interests	53,349	44,972
Total equity	1,038,995	976,323
Total liabilities and equity	$ 2,000,986	$ 1,856,968